According to Bi et al., 2018, downregulation of RPN2 may affect cell proliferation, apoptosis, migration, and invasion in CRC by inhibiting activation of the JAK2/STAT3 signaling pathway [134]. The gene discussed is RPN2; the disease is colorectal carcinoma.